60th Annual Meeting

October 19 - 27, 2013

Institute 1 (ticket)

Advanced Clinical Psychopharmacology in the DSM-5 Era

With the tremendous expansion of the scientific evidence base, practicing clinicians require ongoing education on optimal approaches to clinical assessment and medical decision making for medication management. This Institute provides practical information for the practicing clinician. Presenters review current psychotropic medications and strategies for their use in pediatric groups, with particular focus on understanding the major medication classes, choosing individual medications within each class, and recognizing appropriate approaches to safety monitoring. Participants learn to identify changes in diagnostic classification based on implementation of DSM-5, name specific medication in each major class of psychotropic drugs, and describe features of a safety management plan.